Depression and Anxiety Symptoms

4

Review clinical trials related to Depression and Anxiety Symptoms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Remote Group Cognitive Behavioral Skills Training for Mexican University Students With Anxiety or Depression

The aim is to assess the effectiveness of remote group cognitive behavioral skills training for reducing symptoms of depression and anxiety among university students in Mexico. The investigators will conduct a two-arm randomised control trial comparing a 10-session online group CBT intervention to a mood monitoring web-based application as an active control group.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Instituto Nacional de Psiquiatría Dr. Ramón de la FuenteUpdated: Aug 21, 2026
Eligibility criteria

Undergraduate student enrolled in one of the participating universities [+3]

Report that a professional gave them a diagnosis of bipolar disorder or psychosi...

Status: Not yet recruiting

IPV Prevention Among FDP

Forcibly displaced women and their male partners experience compounding social and structural vulnerabilities to intimate partner violence (IPV) and mental health challenges, yet rigorous studies or examples of evidence-based interventions that seek to prevent and reduce IPV and mental health problems among forcibly displaced populations (FDPs) who seek asylum and rebuild their lives in the United States (US) are scarce. Guided by the the Assessment, Decision, Adaptation, Production, Topical experts-integration, Training, and Testing (ADAPT-ITT) framework, Cascade Implementation Framework, and NIMH experimental therapeutics approach, we propose to address this gap in research and practice by (1) adapting the Economic and Social Empowerment (EA$E) curriculum for US-based FD Congolese couples, (2) using a hybrid type 2 pilot study design to explore preliminary effects of EA$E-US on IPV, mental health outcomes and intermediary outcomes, and (3) examining implementation processes and outcomes

Participants needed: 107
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: George Mason UniversityUpdated: Aug 20, 2026
Eligibility criteria

18 years or older [+5]

1) not fluent in Kinyarwanda, Kinyamulenge or Kinyabwisha, 2) people who are cur...

Status: Not yet recruiting

CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer Survivors

Cancer-related cognitive impairment (CRCI) affects a large proportion of non-central nervous system cancer survivors and can negatively impact cognitive functioning and daily life. Cognitive rehabilitation has shown promising results in addressing these difficulties. The goal of this pilot randomized controlled trial is to evaluate the feasibility, acceptability, and preliminary efficacy of the CanCOG®- Cognitive Rehabilitation in Cancer program in Portuguese adult cancer survivors with CRCI. Adult non-central nervous system cancer survivors (n=60) will be randomly assigned to receive either the CanCOG® intervention or treatment as usual. CanCOG® is a structured cognitive rehabilitation program designed to help cancer survivors manage cognitive difficulties through cognitive training exercises, psychoeducation, and compensatory strategy training. The program consists of six weekly sessions of 1 hour and 30 minutes each, delivered over six consecutive weeks. Sessions are administered in person in small groups (3-9 participants) and are led by a trained professional. The main focus of the study is to assess feasibility outcomes, including recruitment, retention, adherence to the intervention, and completion of study assessments, as well as acceptability and participant satisfaction. The study will also explore preliminary effects of the intervention on cognitive functioning (both perceived and objective), symptoms of anxiety and depression, and quality of life. Participants will complete assessments at baseline (2 weeks after the intervention), 2 weeks after the intervention, and at 3- and 6-month follow-ups. Some participants (10-15) will also take part in interviews to provide feedback on their experience with the program.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Aveiro UniversityUpdated: Aug 10, 2026Locations: 1
Eligibility criteria

Adults aged 18 to 65 years whose native language is European Portuguese; [+6]

Diagnosis of current severe psychiatric disorders (e.g., schizophrenia, psychosi... [+5]

Status: Recruiting

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.

Participants needed: 300
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Have a history of opioid and/or stimulant use [+5]

Self-reported cognitive impairment that would limit ability to participate in re...